DSP and familial dilated cardiomyopathy: Although uncommon, it was more frequently found in DCM patients with underlying genetic mutations (specifically, FLNC and DSP) and was clearly associated with a significantly high risk of adverse outcomes, including life-threatening arrhythmias, all-cause death, and heart transplantation [25].